Beyond-use date is usually 2830 days after dispensing, so daily users may not finish a 30 mL vial before it expires
16 Melanocytes often appear increased in number, but there is no evidence of proliferative activity
The SURPASS trials, which compared Mounjaro against placebo and active comparators including semaglutide and insulin, monitored patients for up to 40-104 weeks depending on the specific trial
Understanding what to expect and how to manage these effects can make the difference between a successful treatment course and premature discontinuation
Obesity is now recognized as a chronic, relapsing disease associated with increased risk of more than 200 conditions, including [3]: Type 2 diabetes Cardiovascular disease Obstructive sleep apnea Certain cancers Increased overall mortality Beyond individual patient risk, the system-level burden is substantial
In this context, any cognitive or behavioral benefits remain secondary and unproven